We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...
Investors react to the Federal Reserve's policy decision and Chairman Jerome Powell's press conference, as well as results ...
We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we ...
The vice chairman and chief investment officer of Affinius Capital has steered the firm since its 2023 rebranding from Square ...
ReGen Brands is building a CPG industry focused on regenerative practices through combining education, community, and aligned ...
Justin Horowitz has been surfing the IOS wave with clients for five years now as it becomes an increasingly institutionalized ...
Keppel REIT is in good financial health. As of Dec. 31, 2024, gearing of 41.2% is well below the 50% regulatory limit. This implies that asset values need to fall 17% in order to breach this limit, ...
The building was temporarily converted into an overflow hospital during the COVID-19 pandemic. The CA left the building in ...
If the General Services Administration becomes a target for cost cuts, the shift could impact markets both within and outside ...
The financial world is bracing itself with the news of Capital One’s ($COF) $35.3 billion all-stock acquisition of Discover ...
Capital One posted a messy fourth quarter, with less top-line growth than many peers. Read more to see why I rate COF stock a ...
In a report released yesterday, Keith Horowitz from Citi reiterated a Buy rating on Capital One Financial (COF – Research Report), with a price ...